课题基金 / 基金详情

Mechanism and gene expression of mesodermal inducing substances on the presumptive ectoderm of early amphibian development.

Mechanism and gene expression of mesodermal inducing substances on the presumptive ectoderm of early amphibian development.
早期两栖动物发育推定外胚层中胚层诱导物质的机制和基因表达。
批准号:
62540555
负责人:
ASASHIMA Makoto
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1987
资助国家:
日本
项目状态:
已结题
起止时间:
1987 至 1989

项目摘要

项目成果

ASASHIMA Makoto的其他基金

相似基金

相关文献

中文摘要
翻译
最近,研究了这些蛋白质的转化生长因子β(TGF-β)家族蛋白质、猪红细胞结合素A和激活素A(红细胞分化因子)的中胚层诱导作用。用激活素A处理外植体导致中胚层衍生物如间充质、脊索、血细胞和肌肉的分化,但白蛋白A的作用要小得多。激活素A以10-50 ng/ml的极低浓度作用于假定的外胚层。激活素A诱导的中胚层分化也通过使用针对肌肉肌球蛋白的多克隆抗体的分析来证实。通过间接免疫荧光分析,在激活素A处理的外植体中观察到肌肉块的分化,而在白蛋白A处理的外植体和对照外植体中没有观察到分化。这些发现证实了TGF-β家族的这种蛋白质具有中胚层诱导能力。为了寻找与激活素同源的基因。从非洲爪蟾自身克隆了三种c-DNA。有C4,B3和M4。为了进一步的实验,将需要检测这些mRNA是否在正常胚胎发育过程中表达。
英文摘要
Recently the mesoderm-inducing effects of the transforming growth factor beta(TGF-beta) family of proteins of these proteins, porcine inhibin A and activin A (erythroid differentiation factor) were examined. Treatment of explants with activin A led to differentiation of mesodermal derivatives such as mesenchyme, notochord, blood cells and muscle, but inhibin A had a much lesser effect. Activin A reacted on presumptive ectoderm with very low concentration at 10-50 ng/ml. The mesodermal differentiation induced by activin A was also confirmed by analyses using a polyclonal antibody against muscle myosin. By indirect immunofluorescence analysis, the differentiation of muscle blocks was observed in the activin-A-treated explants, whereas no differentiation was observed in inhibin-A-treated and control explants. These findings confirm that this protein of the TGF-beta family has mesoderm-inducing ability. To find out the activin-homology genes were tried. Three kinds of c-DNA were cloned from Xenopus itself. There are named C4, B3,and M4. For further experiments will be needed to detect whether these m-RNA are expressed during the normal embryonic development.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Asashima,M.,G.M.Malacinski,and S.C.Smith: "Surgical manipulation of embryos. In:Developmental Biology of the Axolotl.Eds.J.B.Armstrong and G.M.Malacinski." Oxford University Press. 255-263 (1989)
Asashima, M.、G.M.Malacinski 和 S.C.Smith:“胚胎的手术操作。见:蝾螈的发育生物学。J.B.Armstrong 和 G.M.Malacinski 编辑。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 16 条
    Mammalian organ regeneration method using the roadmap for amphibian organogenesis.
    • 批准号:
      21241048
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $25.63万
    • 财政年份:
      2009
    • 负责人:
      ASASHIMA Makoto
    • 依托单位:
    Molecular bases of the body-plan in vertebrate
    • 批准号:
      09275101
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas (A)
    • 资助金额:
      $48.7万
    • 财政年份:
      2001
    • 负责人:
      ASASHIMA Makoto
    • 依托单位:
    Moleculer mechanisms of cell differentiation and morphogenesis during early animal development
    • 批准号:
      07408023
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $22.78万
    • 财政年份:
      1995
    • 负责人:
      ASASHIMA Makoto
    • 依托单位:
    Molecular analysis of cell differentiation and morphogenesis by mesoderm inducing factor
    国内基金
    海外基金
    Activin A诱导单核来源的朗格汉斯细胞在皮肤黑素瘤早期免疫抑制微环境形成中的作用及机制研究
    • 批准号:
      JCZRYB202500430
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    肾衰营养胶囊通过Activin A调节肾-骨 骼肌交互轴改善CKD-PEW的作用及机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      胡蓉
    • 依托单位:
    SNORA14A/MT2A抗氧化轴失调介导Activin-A表达增加促进肝母细胞瘤进展的机制及临床价值研究
    • 批准号:
      82302615
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      朱佳蓓
    • 依托单位:
    瘤内血小板通过Activin A/Smad3/PD-L1重编程肿瘤间质介导卵巢癌免疫逃逸的机制研究
    • 批准号:
      82303367
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      高越
    • 依托单位: